LLOYD A ROWLAND
CIK 1236395 · General Counsel · last filed 2025-03-20
LLOYD A ROWLAND is a General Counsel who has filed 51 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $6.1K of CTMX on Mar 20, 2025. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $381.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$381.5K
3
51
-$1.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTMX | General Counsel | 120,594 | $3.01 | $363.0K | $46.0K | 19 | 2025-03-20 |
| XNCR | Sr. V.P. and General Counsel | 1,501 | $12.33 | $18.5K | $0 | 5 | 2016-01-28 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | VP, Chief Compliance Officer | 39,091 | — | — | -$1.33M | 26 | 2012-07-26 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-20 | CTMX | Sell (S) | −10,203 | -$6.1K | EDGAR |
| 2024-08-22 | CTMX | Mixed | +7,069 | -$5.1K | EDGAR |
| 2024-03-21 | CTMX | Sell (S) | −5,268 | -$11.0K | EDGAR |
| 2024-01-19 | CTMX | Grant (A) | +25,000 | $0 | EDGAR |
| 2023-12-22 | CTMX | Sell (S) | −4,077 | -$5.6K | EDGAR |
| 2023-12-19 | CTMX | Exer (M) | +11,250 | $0 | EDGAR |
| 2023-09-22 | CTMX | Mixed | +9,514 | -$7.1K | EDGAR |
| 2023-03-20 | CTMX | Sell (S) | −2,037 | -$4.0K | EDGAR |
| 2023-02-06 | CTMX | Grant (A) | +25,000 | $0 | EDGAR |
| 2022-08-12 | CTMX | Grant (A) | — | $0 | EDGAR |